Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Total Liabilities (2020 - 2025)

Stemtech's Total Liabilities history spans 6 years, with the latest figure at $10.3 million for Q3 2025.

  • For Q3 2025, Total Liabilities changed N/A year-over-year to $10.3 million; the TTM value through Sep 2025 reached $10.3 million, changed N/A, while the annual FY2024 figure was $9.0 million, 39.42% up from the prior year.
  • Total Liabilities for Q3 2025 was $10.3 million at Stemtech, roughly flat from $10.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $33.5 million in Q2 2022 and bottomed at -$896097.0 in Q1 2021.
  • The 5-year median for Total Liabilities is $9.0 million (2022), against an average of $9.0 million.
  • The largest annual shift saw Total Liabilities skyrocketed 13408.51% in 2022 before it plummeted 82.94% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $9.7 million in 2021, then fell by 23.51% to $7.4 million in 2022, then decreased by 13.13% to $6.5 million in 2023, then skyrocketed by 39.42% to $9.0 million in 2024, then grew by 14.35% to $10.3 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Total Liabilities are $10.3 million (Q3 2025), $10.3 million (Q2 2025), and $9.4 million (Q1 2025).